What is a transforaminal epidural steroid (TESI) injection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Transforaminal Epidural Steroid Injection (TFESI)?

A transforaminal epidural steroid injection (TFESI) is a fluoroscopically-guided interventional procedure that delivers corticosteroids and local anesthetic directly into the epidural space through the neural foramen, targeting the specific nerve root causing radicular pain. 1

Technical Procedure

TFESI is performed under fluoroscopic guidance with specific technical requirements:

  • The needle is inserted at a predetermined angle toward the superior-anterior aspect of the neural foramen, with the C-arm fluoroscope positioned for optimal visualization at angles that vary by spinal level. 2

  • Both anteroposterior (AP) and lateral fluoroscopic views must be obtained to confirm needle tip position at the superior-anterior aspect of the foramen before injection. 2

  • Contrast dye is injected first to confirm proper epidural spread along the nerve root and rule out intravascular placement before therapeutic injection. 2

  • The therapeutic injection consists of corticosteroid mixed with local anesthetic, typically delivered after confirming negative intravascular flow and appropriate contrast spread pattern. 2

  • Fluoroscopic guidance is non-negotiable and considered the gold standard for all transforaminal epidural injections to ensure accurate needle placement and minimize complications. 2, 3

Clinical Indications

The American Society of Anesthesiologists and recent BMJ guidelines provide clear criteria for when TFESI is appropriate:

  • TFESI is strongly recommended specifically for radicular pain or radiculopathy, not for axial back pain alone. 1, 4

  • Patients must have radicular pain radiating below the knee with corresponding MRI evidence of nerve root compression from disc herniation, spinal stenosis, or post-surgical changes. 2, 4

  • Conservative treatment failure for at least 4-6 weeks is required, including physical therapy, NSAIDs, and activity modification before considering TFESI. 2, 3

  • Strong recommendations exist in favor of fluoroscopically-guided lumbar transforaminal epidural injections for chronic spine pain associated with disc herniation, spinal stenosis, axial discogenic pain, and post-surgery syndrome. 1

Contraindications and Inappropriate Use

Recent guidelines provide strong recommendations against TFESI in specific scenarios:

  • The 2025 BMJ guideline provides a strong recommendation AGAINST epidural injections for chronic axial spine pain without radiculopathy, stating "all or nearly all well-informed people would likely not want such interventions." 2, 4

  • The American Academy of Neurology explicitly recommends against epidural steroid injections for non-radicular low back pain, as evidence for benefit is limited. 2, 4

  • TFESI should not be performed for mechanical back pain from spondylosis, facet arthropathy, or sacroiliac joint pathology in the absence of true radiculopathy. 4

Risks and Complications

TFESI carries a higher risk profile than interlaminar approaches and requires specific informed consent:

  • Common complications include dural puncture, insertion-site infections, sensorimotor deficits, cauda equina syndrome, discitis, epidural granuloma, and retinal complications. 2, 3

  • Rare but catastrophic complications include paralysis, spinal cord infarction, and death, which can occur at any spinal level despite proper technique. 1, 2

  • Shared decision-making must include explicit discussion of these serious complications before proceeding with the procedure. 2, 3

Efficacy and Repeat Injections

Evidence supports specific criteria for determining treatment success and appropriateness of repeat injections:

  • Repeat TFESI with steroid is appropriate only if the initial injection resulted in at least 50% pain relief lasting at least 2 months. 2, 3

  • Research demonstrates that 59% of patients with discogenic pain and 35% of patients with spinal stenosis achieve greater than 50% improvement at one year. 5

  • The transforaminal approach produces better short-term pain improvement and fewer long-term surgical interventions compared to interlaminar epidural injections for symptomatic lumbar disc herniation. 6

  • Mean duration of injection effect is approximately 12.5 months, with the most effective period being the first 5 months post-injection. 7

Multimodal Treatment Context

TFESI should never be used as monotherapy:

  • Epidural steroid injections must be provided as part of a comprehensive pain management program that includes physical therapy, patient education, psychosocial support, and oral medications. 2, 3

  • The procedure is intended to provide temporary symptomatic relief to facilitate participation in rehabilitation, not as maintenance therapy for chronic pain. 3

Related Questions

What is the role of epidural steroid injections (ESI) in treating lumbar spine conditions?
Are facet joint injections, sacroiliac joint injections, trigger point injections, transforaminal epidural injections, and steroid injection to the greater trochanter medically necessary for a patient with persistent low back pain and radiculopathy?
What is the recommended follow-up plan after lumbar transforaminal epidural steroid injections (LTESI)?
Is an L5-S1 midline epidural steroid injection (ESI) approved for a patient with lower back pain, numbness, tingling, and weakness in both legs, despite lack of imaging evidence showing compression of the involved spinal nerve roots?
Is a right L3-4 and L4-5 transforaminal epidural steroid injection medically necessary for a patient with chronic low back and right leg radicular pain, severe central stenosis at L4-5, and right recess stenosis?
What is the diagnosis and recommended management for an adult with a recently resolved productive cough with yellow-green phlegm?
What is the role of Edaravone (generic name) in treating acute ischemic stroke in patients, particularly older adults or those with significant comorbidities such as hypertension, diabetes, or previous stroke?
What is Spinal Cerebellar Ataxia type 14 (SCA14)?
What treatment options are available for a postmenopausal woman with hypoactive sexual desire disorder (Low Libido)?
Is it acceptable to prescribe oral Ativan (lorazepam) to an adult patient with anxiety prior to a morning Magnetic Resonance Imaging (MRI) procedure, considering their medical history and potential risks?
What are the treatment recommendations for a patient with Parkinsonism experiencing pro facial dyskinesia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.